ALS medication AMX0114 has been well tolerated in early clinical testing, and is now moving to a second, higher-dose trial ...

Columnist Juliet Taylor and her late husband, Jeff, fought hard for precious holiday moments after he was diagnosed with ALS.

Slowing down in a fast-paced world while living with ALS isn’t surrendering, writes columnist. It’s an active choice to be ...

Actor Eric Dane is joining nonprofit Target ALS on a campaign aiming to raise $500,000 for ALS research by Dec. 31.

The ALS Association awarded a $1 million grant to support a clinical trial testing Pasithea's MEK inhibitor PAS-004 in people ...

While briefly changing roles with her husband, columnist Kristin Neva got a glimpse of how frustrating it is to have difficulty speaking.

The ALS Association is awarding $2.14 million in grants to help clinics across the U.S. strengthen multidisciplinary care for ...

Clene is planning to submit an application to the FDA in early 2026 requesting the accelerated approval of CNM-Au8 for ALS.

Neurosense Therapeutics said it will seek conditional approval of PrimeC as an ALS treatment in Canada in mid-2006.

A Phase 2 trial to test the use of nasal spray foralumab for the treatment of ALS has been accepted into the Healey ALS ...

Three years after the death of her husband, Craig, from ALS, guest writer Anita Newton struggles with coming home to an empty ...

The FDA has cleared Neurosense to begin its pivotal Phase 3 clinical trial of PrimeC for the treatment of amyotrophic lateral ...